论文部分内容阅读
目的观察重症支气管哮喘患者早期,在应用无创正压通气治疗之后的临床效果。方法 32例重症支气管哮喘急性发作的患者,随机分为治疗组和对照组,每组16例,治疗组在患者入院之后给予无创正压通气治疗,对照组仅仅给予常规的药物治疗。将两组分别治疗2、24、48 h后,观察患者相应的临床表现、生命体征以及其他气血的检查结果。最后对患者的住院时间进行对比,比较两组不同治疗方法患者所需的治愈时间。结果在相同时段,治疗组的生命体征、临床表现等都比对照组疗效好,而且治愈时间比对照组要低许多,差异有统计学意义(P<0.05)。结论应用无创正压通气治疗对重症支气管哮喘具有较好的效果,值得在临床上进行推广。
Objective To observe the clinical effect of patients with severe bronchial asthma in the early stage after noninvasive positive pressure ventilation. Methods Thirty-two patients with acute exacerbation of severe bronchial asthma were randomly divided into treatment group (n = 16) and control group (n = 16). Non-invasive positive pressure ventilation was given to the patients in the treatment group and routine drugs were given to the control group. The two groups were treated for 2, 24, 48 h after the observation of the patient’s clinical manifestations, vital signs and other blood test results. Finally, the patient’s hospital stay compared to compare the two groups of patients with different treatment time required for the cure. Results In the same time period, the vital signs and clinical manifestations of the treatment group were better than those of the control group, and the healing time was much lower than that of the control group (P <0.05). Conclusion The application of noninvasive positive pressure ventilation has a good effect on severe bronchial asthma, which is worth to be popularized clinically.